Contexium

DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Development Award

DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Development Award is a published development and funding opportunity on Contexium. The donor or funder is Defense Health Agency Contracting Activity - DHACA. Project location(s): United States. Applications close on 30 Sep 2026. Summary: The fiscal year 2026 (FY26) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Therapeutic Development Award (TDA) supports research ranging from preclinical validation of therapeutic leads through U.S. Food and Drug Administration (FDA) Investigational New Drug (IND)-enabling studies.…

Opportunity overview

Project name
DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Development Award
Defense Health Agency Contracting Activity - DHACA logo
Defense Health Agency Contracting Activity - DHACA
Donor
Defense Health Agency Contracting Activity - DHACA

Key details

Opportunity start date
Opportunity end date
Project location(s)
United States

Summary

Summary: The fiscal year 2026 (FY26) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Therapeutic Development Award (TDA) supports research ranging from...

Frequently asked questions

What is DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Development Award?

DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Development Award is a published development and funding opportunity on Contexium. The donor or funder is Defense Health Agency Contracting Activity - DHACA. Project location(s): United States. Applications close on 30 Sep 2026. Summary: The fiscal year 2026 (FY26) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Therapeutic Development Award (TDA) supports research ranging from preclinical validation of therapeutic leads through U.S. Food and Drug Administration (FDA) Investigational New Drug (IND)-enabling studies.…

Who is funding DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Development Award?

DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Development Award is funded by Defense Health Agency Contracting Activity - DHACA.

When is the deadline to apply for DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Development Award?

The application deadline is 30 Sep 2026 00:00 (UTC).

Where will the DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Development Award project take place?

The project location(s) are: United States.

How can I apply for DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Development Award?

Create a free Contexium account to view the full opportunity details and submit an application via the marketplace.